Related by context. Frequent words. (Click for all words.) 75 Improves Survival 74 FDA Clears 73 Completes Enrollment 73 Drug Candidate 73 Phase III Trial 72 Receives Orphan Drug Designation 72 Patient Enrollment 71 Announces FDA Clearance 71 Patients Undergoing 71 Heart Failure Patients 71 Clinical Trial Results 70 Patients Treated 70 Increases Risk 70 Study Demonstrates 69 Receives FDA Clearance 69 Phase III Clinical Trial 69 Elderly Patients 69 Pediatric Patients 69 Pivotal Study 68 Renal Cell Carcinoma 68 Initiates Phase II 68 Significantly Improves 68 Drug Resistant 68 Prostate Cancer Patients 68 Single Dose 68 Achieves Milestone 68 Prostate Cancer Treatment 68 Reduces Risk 68 Cholesterol Drug 67 Metastatic Colorectal Cancer 67 Face Transplant 67 Advanced Prostate Cancer 67 Pivotal Trial 67 Gene Mutation 67 Chronic Hepatitis C 67 FDA Clearance 66 Shows Promise 66 II Clinical Trial 66 FDA Accepts 66 Blood Thinner 66 Preclinical Data 66 Cholesterol Drugs 66 Lung Cancer Patients 66 Gastric Cancer 66 Commences Phase 66 Announces Initiation 65 Overactive Bladder 65 Survival Rates 65 Holds Promise 65 Inhibits 65 Initiate Phase 65 Blood Clots 65 Presents Positive 65 Autoimmune Disease 65 Metastatic Melanoma 65 Announces Issuance 65 Breast Cancer Treatment 65 Develop Novel 65 Pivotal Phase 64 Chronic Hepatitis B 64 Urinary Tract Infections 64 Chronic Heart Failure 64 Post Operative 64 Pivotal Phase III 64 Hormone Therapy 64 Increased Risk 64 FDA Warns 64 Significantly Reduces 64 FDA Approves 64 Well Tolerated 64 Epratuzumab 64 Pulmonary Arterial Hypertension 63 Generic Version 63 Treatable 63 Malignancies 63 Helps Prevent 63 Myelofibrosis 63 Announces Presentation 63 Kidney Failure 63 Bypass Surgery 63 Significantly Increases 63 Low Dose 63 Cancer Treatments 63 Diabetic Patients 63 Blood Vessels 63 Tumor Growth 63 Initiates Phase 63 Protects Against 63 Patent Issued 63 Autoimmune Diseases 63 Premature Babies 63 Stomach Cancer 62 Gum Disease 62 Venous Thromboembolism 62 Smallpox Vaccine 62 Patent Covering 62 #.#/Share [002] 62 Researchers Identify 62 Cardiovascular Events 62 Int J 62 Clinical Trials Update